112 related articles for article (PubMed ID: 685891)
21. Bone changes during prednisone treatment.
Deding A; Tougaard L; Krogh Jensen M; Rodbro P
Acta Med Scand; 1977; 202(4):253-5. PubMed ID: 562590
[TBL] [Abstract][Full Text] [Related]
22. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
Hahn TJ; Halstead LR; Strates B; Imbimbo B; Baran DT
Calcif Tissue Int; 1980; 31(2):109-15. PubMed ID: 6770974
[No Abstract] [Full Text] [Related]
23. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
[TBL] [Abstract][Full Text] [Related]
24. Bone mineral content in myelomatosis.
Ingeberg S; Deding A; Jensen MK
Acta Med Scand; 1982; 211(1-2):19-21. PubMed ID: 7072520
[TBL] [Abstract][Full Text] [Related]
25. Long term follow-up of bone mineral status in children with renal disease.
Chesney RW; Rose P; Mazess RB; DeLuca HF
Pediatr Nephrol; 1988 Jan; 2(1):22-6. PubMed ID: 3152995
[TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
[TBL] [Abstract][Full Text] [Related]
27. Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.
McAdams AJ; McEnery PT; West CD
J Pediatr; 1975 Jan; 86(1):23-31. PubMed ID: 1089142
[TBL] [Abstract][Full Text] [Related]
28. Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone.
Polito C; Di Toro R
Child Nephrol Urol; 1992; 12(4):202-7. PubMed ID: 1473093
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
Chan JC; Kodroff MB; Landwehr DM
Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
[TBL] [Abstract][Full Text] [Related]
31. Normal growth of nephrotic children during long-term alternate-day prednisone therapy.
Polito C; Oporto MR; Totino SF; La Manna A; Di Toro R
Acta Paediatr Scand; 1986 Mar; 75(2):245-50. PubMed ID: 3962658
[TBL] [Abstract][Full Text] [Related]
32. Juvenile periodontitis: skeletal bone mineral content.
Von Wowern N; Stoltze K
J Clin Periodontol; 1977 Nov; 4(4):272-7. PubMed ID: 271654
[TBL] [Abstract][Full Text] [Related]
33. Calcium homeostasis and mineralization in puberty.
Krabbe S
Dan Med Bull; 1989 Apr; 36(2):113-24. PubMed ID: 2651027
[TBL] [Abstract][Full Text] [Related]
34. Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate.
Elzouki AY; Jaiswal OP
Clin Pediatr (Phila); 1988 Aug; 27(8):387-92. PubMed ID: 3135974
[TBL] [Abstract][Full Text] [Related]
35. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition.
Burnham JM; Shults J; Semeao E; Foster B; Zemel BS; Stallings VA; Leonard MB
J Bone Miner Res; 2004 Dec; 19(12):1961-8. PubMed ID: 15537438
[TBL] [Abstract][Full Text] [Related]
36. Growth and development of children with renal transplants. Use of alternate-day steroid therapy.
McEnery PT; Gonzalez LL; Martin LW; West CD
J Pediatr; 1973 Nov; 83(5):806-14. PubMed ID: 4582575
[No Abstract] [Full Text] [Related]
37. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
Rooney M; Davies UM; Reeve J; Preece M; Ansell BM; Woo PM
J Rheumatol; 2000 Apr; 27(4):1073-81. PubMed ID: 10782840
[TBL] [Abstract][Full Text] [Related]
38. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
39. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Navarro FA; Hanauer SB; Kirschner BS
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
[TBL] [Abstract][Full Text] [Related]
40. Correlation of radial bone mineral content with total body calcium in chronic renal failure.
Cohn SH; Ellis KJ; Caselnova RC; Asad SN; Letteri JM
J Lab Clin Med; 1975 Dec; 86(6):910-9. PubMed ID: 1194756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
